EUVIMEDΑνακαλύψτε το EUVIMED
Open access · CC BY-NC-ND 4.0

Tuberculosis Preventive Therapy in the Era of Primary Drug Resistance: A Primum Non Nocere Reappraisal

Sunil Kumar Raina

Journal of Public Health and Primary Care · 2026-09 · 7 (3) · 135-139

DOI: 10.4103/jphpc.jphpc_11_26 ↗

At a glance

Journal article in Journal of Public Health and Primary Care, published online on 2026-08-17. Written by Sunil Kumar Raina. 16 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

ΠερίληψηΒιβλιογραφικά στοιχείαCiteRelated studies

Abstract (original language)

The assumption that anti-TB drugs function purely as bactericidal agents, with immune function as a passive benefit, reflects neither the known pharmacology of these compounds nor the dynamic biology of the latent state. Together, these realities invoke the oldest and most fundamental principle of medical ethics: primum non nocere; first, do no harm. It is the argument of this paper that TPT, as currently deployed in high-resistance settings, may, in a biologically definable and clinically significant subset of patients, cause measurable net harm and that this possibility has not been given the scientific or ethical weight it deserves.

Cite

APA

Raina, S. K. (2026). Tuberculosis Preventive Therapy in the Era of Primary Drug Resistance: A Primum Non Nocere Reappraisal. Journal of Public Health and Primary Care, 7(3), 135-139. https://doi.org/10.4103/jphpc.jphpc_11_26

Vancouver

Raina SK. Tuberculosis Preventive Therapy in the Era of Primary Drug Resistance: A Primum Non Nocere Reappraisal. Journal of Public Health and Primary Care. 2026;7(3):135-139. doi:10.4103/jphpc.jphpc_11_26

BibTeX
@article{Raina2026,
  author = {Raina, Sunil Kumar},
  title = {Tuberculosis Preventive Therapy in the Era of Primary Drug Resistance: A Primum Non Nocere Reappraisal},
  journal = {Journal of Public Health and Primary Care},
  year = {2026},
  volume = {7},
  number = {3},
  pages = {135--139},
  doi = {10.4103/jphpc.jphpc_11_26}
}
Start for free →